首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cns & neurological disorders-drug targets

缩写:CNS NEUROL DISORD-DR

ISSN:1871-5273

e-ISSN:1996-3181

IF/分区:3.3/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引1974条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Elena F Shevtsova,Daria V Vinogradova,Margarita E Neganova et al. Elena F Shevtsova et al.
Background: A considerable amount of data suggests the age-related impairments of mitochondrial functions in the development of sporadic forms of neurodegenerative pathologies. Mitochondria and the phenomenon of mitochond...
Pronit Biswas,Pooja Mishra,Devasish Bose et al. Pronit Biswas et al.
Background: Since ancient times, the use of cannabis as a medicine is well documented due to its potential therapeutic activity while subsequently its use as drug of abuse spread increasingly. ...
Gianluca Serafini,Giulia Adavastro,Giovanna Canepa et al. Gianluca Serafini et al.
Treatment resistant depression (TRD) and suicidal behavior are among the most important public health problems and are commonly associated with significant disability and psychosocial impairment. Although there have been recent advances in ...
Giovanni Martinotti,Rita Santacroce,Duccio Papanti et al. Giovanni Martinotti et al.
Background: Synthetic Cannabinoids (SC) are the widest and most diffused class of Novel Psychoactive Substances. The short- and long- term health risks associated with the consumption of SC are often unknown to both users...
Ana Lucia Arellano,Esther Papaseit,Anna Romaguera et al. Ana Lucia Arellano et al.
Background & objective: Cannabis is the most widely used illicit drug. The two most important natural cannabinoids are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). The THC content of cannabis has been increas...
Renata Solimini,Maria Concetta Rotolo,Simona Pichini et al. Renata Solimini et al.
Background & objective: Medical cannabis is increasingly used as a treatment or adjunct treatment with different levels of efficacy in several neurological disorders or related symptoms (such as multiple sclerosis, autism...
Carmen Mannucci,Michele Navarra,Fabrizio Calapai et al. Carmen Mannucci et al.
Background: Cannabidiol (CBD) is among the major secondary metabolites of Cannabis devoid of the delta-9-tetra-hydrocannabinol psychoactive effects. It is a resorcinol-based compound with a broad spectrum of potential the...
Laura Orsolini,Duccio Papanti,John Corkery et al. Laura Orsolini et al.
Background: Substance use, including cannabis, has been documented amongst women both in the pre-conception period and during pregnancy, particularly during the 1st trimester, which is clearly the most critical period in ...